Scarica l'app Stockscreener
234.75
4.39%
-10.77
Pre-mercato:
234.00
-0.75
-0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$245.52
Aprire:
$238.31
Volume 24 ore:
364.84K
Relative Volume:
1.34
Capitalizzazione di mercato:
$6.57B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-8.5895
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-5.02%
1M Prestazione:
-8.46%
6M Prestazione:
-30.36%
1 anno Prestazione:
-28.47%
Intervallo 1D:
$233.34
$239.94
Intervallo di 1 settimana:
$233.34
$248.00
Portata 52W:
$233.34
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
234.75 | 6.57B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
131.63 | 228.29B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
98.50 | 145.69B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
368.15 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.89 | 112.70B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.98 | 42.75B | 5.72B | 4.17B | 259.90M | 6.97 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Bio-Rad stock touches 52-week low at $234.81 amid market shifts - Investing.com India
Should You Continue to Hold Bio-Rad Stock in Your Portfolio? - Yahoo Finance
Electroporation Instruments Market Projected To Witness - openPR.com
Protein Engineering Market Deep Research 2025-2032 | Agilent - openPR.com
Enzyme Linked Immunosorbent Assay Market Deep Research Report - openPR.com
Autoimmune Disease Diagnostics Market Is Booming So Rapidly - openPR.com
Cell-Free Protein Expression Market Detailed Analysis - openPR.com
Dna Sequencing Equipment And Services Market 2025: Sustainable - openPR.com
Biomarker Research Services Market Is Booming Worldwide - openPR.com
Porphyria Treatment Market Growth in Future Scope 2025-2032 | - openPR.com
Jefferies cuts Bio-Rad Labs target to $285, maintains Hold By Investing.com - Investing.com Canada
Life Science Products Market Projected To Witness Substantial - openPR.com
HIV Diagnostics Test Market Projected To Witness Substantial - openPR.com
Cancer Biomarkers Market: Emerging Trends, Growth Drivers & - openPR
Bio-Rad stock touches 52-week low at $243.94 amid market shifts By Investing.com - Investing.com South Africa
Bio-Rad stock touches 52-week low at $243.94 amid market shifts - Investing.com Australia
Chromatography Data System Market Generated Opportunities, - openPR
High End Cellomics Market Set to Witness Significant Growth - openPR
Flow Cytometry Market Is Booming Worldwide | Luminex - openPR
Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund - MSN
Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed - MSN
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts -March 24, 2025 at 04:06 pm EDT - Marketscreener.com
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts - StreetInsider.com
Oncocyte Secures Game-Changing Bio-Rad Deal and $57M War Chest for $1B Market Push - StockTitan
Clinical Diagnostics Market is Projected to Increase at a CAGR - openPR.com
Monoclonal Antibody Diagnostic Reagents Market Growth - openPR
Oncocyte secures $29.1 million to advance FDA assay - MSN
Bio-Rad Launches XP-Design Assay Salmonella Serotyping Solution for Food Safety Testing - Technology Networks
Enzyme Linked Immunosorbent Assay Market Growth Analysis: - openPR
South East Asia And South Asia Industrial Microbiology Market - openPR
Life Science Products Market Is Booming Worldwide 2025-2032 | - openPR
Hemoglobin A1c Testing Devices Market Projected To Witness - openPR
Learn to Evaluate (BIO) using the Charts - news.stocktradersdaily.com
Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? - simplywall.st
Cancer Biomarkers Market Size, Share, Growth Factors, - openPR
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Blotting Machine Market Future Business Opportunities - openPR
Where are the Opportunities in (BIO.B) - Stock Traders Daily
The Future of Genetic Testing: Industry Growth, Trends & Key - openPR
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Bio-Rad Laboratories, - EIN News
Transcriptomics Technologies Market Future Business - openPR
Salmonella serotyping solution enhances food safety testing - Labmate Online
New XP-Design Assay Salmonella Serotyping Solution for Rapid, Accurate Food Safety Testing - Food Safety Magazine
Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing - Cambridge Network
Newborn Screening Market Growth in Future Scope 2025-2032 | - openPR
Charles Schwab Investment Management Inc. Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Laboratory Supplies Market Generated Opportunities, Future - openPR
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
ChemiDoc Go Imaging System - the-scientist.com
HIV Rapid Test Kits Market Focused Insights 2025-2030: Abbott, Bio-Rad, and bioMerieux Strengthen Market Position Amid Rising Competition - Yahoo Finance
Stem Cell Assay Market Demand, Industry Growth and Future Scope - openPR
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.71%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):